Comparison of Whole Body DWI to FDG PET

NCT06630845 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Cancer

Interventions

DRUG: Fluorodeoxyglucose F18
PROCEDURE: Positron Emission Tomography combined with Magnetic resonance imaging (PET/MRI)
PROCEDURE: Whole Body Magnetic Resonance Imaging with Diffusion-Weighted Imaging (WB-MRI-DWI)
DEVICE: General Electric (GE) SIGNA PET/MR

Sponsor

University of California, San Francisco

Collaborators

[object Object]
[object Object]